The corporate investment arm of Bupa, Bupa Ventures invests at the Seed – Series A stage with the ability to follow-on in future rounds. It supports and invests in start-ups that are focused on developing innovative models of healthcare that enable better health outcomes.
The NRFC offers debt finance, equity finance and guarantees for compelling proposals in seven priority areas of the Australian economy. Proposals must be solely or mainly Australian-based, generate positive public policy outcomes, and demonstrate a positive return on investment or the ability to repay debt, among other requirements.
The Venture Capital Limited Partnership program offers tax benefits to fund managers and eligible foreign investors to help stimulate venture capital investment. Benefits include an exemption for eligible foreign investors from capital gains tax on their share of a fund’s returns from eligible venture capital investments.
The Australian Venture Capital Fund of Funds (AFOF) program encourages investment in a portfolio of early stage venture capital limited partnerships (ESVCLPs) and venture capital limited partnerships (VCLPs). It offers tax incentives and provides diversification and flexibility for the fund and its investors.
Early Stage Venture Capital Limited Partnerships provides fund managers and investors with support to help stimulate early stage venture capital investments. Benefits include tax exemptions on an investor’s share of a fund’s income and tax gains.
The Biomedical Translation Fund (BTF) provides companies with venture capital through licensed private sector fund managers. It will help you to develop your biomedical discoveries into tangible products, services and outcomes.
ALIAVIA Ventures is a California based firm focused on early stage venture capital investing in U.S and Australian based female founders building world-changing enterprise and consumer tech companies.
Early stage capital propelling Australian & New Zealand companies across the globe